Truist Financial Corp Mannkind Corp Transaction History

Truist Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$2.62 - $4.45 $52,400 - $89,000	-20,000 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$3.89 - $5.48 $778 - $1,096	-200 Reduced 0.99%	20,000 $87,000
Q1 2021 May 17, 2021	BUY	$3.14 - $6.14 $12,669 - $24,774	4,035 Added 24.96%	20,200 $79,000
Q4 2020 Feb 18, 2021	BUY	$1.79 - $4.04 $28,935 - $65,306	16,165 New	16,165 $51,000

244

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.